Data |
Descrição |
Vacina |
Quantidade 1° dose |
Quantidade 2° dose |
Quantidade 1° dose extra |
Quantidade 2° dose extra |
Quantidade de doses indigena |
Total |
31/01/2022 |
219VCD288Z |
Fiocruz/Oxford/AstraZeneca |
0 |
0 |
0 |
0 |
0 |
165 |
03/02/2022 |
210461 |
Butantan/CoronaVac |
25 |
25 |
0 |
0 |
0 |
50 |
03/02/2022 |
210439A |
Butantan/CoronaVac |
60 |
60 |
0 |
0 |
0 |
120 |
03/02/2022 |
FP8290 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
60 |
60 |
0 |
0 |
0 |
120 |
07/02/2022 |
2019VCD292Z |
Fiocruz/Oxford/AstraZeneca |
0 |
0 |
0 |
0 |
0 |
200 |
11/02/2022 |
C202107128 |
Butantan/CoronaVac |
15 |
0 |
0 |
0 |
0 |
15 |
11/02/2022 |
FN5988 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
120 |
0 |
0 |
0 |
0 |
120 |
14/02/2022 |
219VCD292Z |
Fiocruz/Oxford/AstraZeneca |
0 |
0 |
0 |
0 |
0 |
50 |
14/02/2022 |
205F21A |
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag |
0 |
0 |
0 |
0 |
0 |
150 |
14/02/2022 |
FM2951 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
0 |
0 |
0 |
0 |
0 |
150 |
21/02/2022 |
C202107131 |
Butantan/CoronaVac |
342 |
0 |
0 |
0 |
0 |
342 |
21/02/2022 |
FRB392 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
0 |
90 |
0 |
0 |
0 |
90 |
22/02/2022 |
21OVCD300Z |
Fiocruz/Oxford/AstraZeneca |
0 |
0 |
0 |
0 |
0 |
200 |
22/02/2022 |
201H21A |
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag |
0 |
0 |
0 |
0 |
0 |
100 |
22/02/2022 |
FM2948 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
0 |
0 |
0 |
0 |
0 |
72 |
03/03/2022 |
21OVCD016VA |
Fiocruz/Oxford/AstraZeneca |
0 |
0 |
0 |
0 |
0 |
200 |
03/03/2022 |
201H21A |
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag |
0 |
0 |
0 |
0 |
0 |
100 |
03/03/2022 |
FM2948 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
0 |
0 |
0 |
0 |
0 |
72 |
03/03/2022 |
C202107128 |
Butantan/CoronaVac |
0 |
0 |
0 |
0 |
0 |
123 |
03/03/2022 |
21OVCD016VA |
Fiocruz/Oxford/AstraZeneca |
0 |
0 |
0 |
0 |
0 |
200 |
03/03/2022 |
201H21A |
Janssen Covid-19 Vaccine |
0 |
0 |
0 |
0 |
0 |
100 |
03/03/2022 |
FM2948 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
0 |
0 |
0 |
0 |
0 |
72 |
03/03/2022 |
210525 |
Butantan/CoronaVac |
0 |
0 |
0 |
0 |
0 |
170 |
08/03/2022 |
21OVCD016VA |
Fiocruz/Oxford/AstraZeneca |
0 |
0 |
0 |
0 |
0 |
200 |
08/03/2022 |
201H21A |
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag |
0 |
0 |
0 |
0 |
0 |
200 |
08/03/2022 |
FN2948 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
0 |
0 |
0 |
0 |
0 |
90 |
08/03/2022 |
C202107128 |
Butantan/CoronaVac |
0 |
15 |
0 |
0 |
0 |
15 |
08/03/2022 |
FR83292 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
0 |
60 |
0 |
0 |
0 |
60 |
08/03/2022 |
21OVCD016VA |
Fiocruz/Oxford/AstraZeneca |
0 |
0 |
0 |
0 |
0 |
200 |
08/03/2022 |
201H21A |
Janssen Covid-19 Vaccine |
0 |
0 |
0 |
0 |
0 |
200 |